EP1343481A4 - PROCESS FOR THE PREPARATION OF A QUICKLY SOLUBLE DOSAGE FORM - Google Patents

PROCESS FOR THE PREPARATION OF A QUICKLY SOLUBLE DOSAGE FORM

Info

Publication number
EP1343481A4
EP1343481A4 EP01270300A EP01270300A EP1343481A4 EP 1343481 A4 EP1343481 A4 EP 1343481A4 EP 01270300 A EP01270300 A EP 01270300A EP 01270300 A EP01270300 A EP 01270300A EP 1343481 A4 EP1343481 A4 EP 1343481A4
Authority
EP
European Patent Office
Prior art keywords
preparation
dosage form
fast dissolving
dissolving dosage
fast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01270300A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1343481A2 (en
Inventor
Deepak Murpani
Rajiv Malik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of EP1343481A2 publication Critical patent/EP1343481A2/en
Publication of EP1343481A4 publication Critical patent/EP1343481A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)
EP01270300A 2000-12-15 2001-12-07 PROCESS FOR THE PREPARATION OF A QUICKLY SOLUBLE DOSAGE FORM Withdrawn EP1343481A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1170DE2000 IN192750B (enrdf_load_stackoverflow) 2000-12-15 2000-12-15
INDE117000 2000-12-15
PCT/IB2001/002354 WO2002047607A2 (en) 2000-12-15 2001-12-07 Process for the preparation of a fast dissolving dosage form

Publications (2)

Publication Number Publication Date
EP1343481A2 EP1343481A2 (en) 2003-09-17
EP1343481A4 true EP1343481A4 (en) 2004-03-17

Family

ID=11097139

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01270300A Withdrawn EP1343481A4 (en) 2000-12-15 2001-12-07 PROCESS FOR THE PREPARATION OF A QUICKLY SOLUBLE DOSAGE FORM

Country Status (4)

Country Link
EP (1) EP1343481A4 (enrdf_load_stackoverflow)
AU (1) AU2002220968A1 (enrdf_load_stackoverflow)
IN (1) IN192750B (enrdf_load_stackoverflow)
WO (1) WO2002047607A2 (enrdf_load_stackoverflow)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
KR100503949B1 (ko) * 2003-04-28 2005-07-26 주식회사유한양행 염산 온단세트론의 쓴맛을 효과적으로 은폐한 경구용 구강속붕해정 조성물
FR2858556B1 (fr) * 2003-08-06 2006-03-10 Galenix Innovations Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
EP1510208A1 (en) 2003-08-22 2005-03-02 Fournier Laboratories Ireland Limited Pharmaceutical composition comprising a combination of metformin and statin
WO2005062722A2 (en) * 2003-11-21 2005-07-14 Sun Pharmaceutical Industries Limited Fexofenadine containing pharmaceutical formulation
US20090060983A1 (en) * 2007-08-30 2009-03-05 Bunick Frank J Method And Composition For Making An Orally Disintegrating Dosage Form
EP2044929A1 (en) * 2007-10-04 2009-04-08 Laboratorios del Dr. Esteve S.A. Oral fast distintegrating tablets
CN101842085B (zh) 2007-10-31 2013-01-30 麦克内尔-Ppc股份有限公司 口腔崩解剂型
DE102008047910A1 (de) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tablettierhilfsstoff auf Laktose- und Cellulosebasis
US8858210B2 (en) 2009-09-24 2014-10-14 Mcneil-Ppc, Inc. Manufacture of variable density dosage forms utilizing radiofrequency energy
US8343533B2 (en) 2009-09-24 2013-01-01 Mcneil-Ppc, Inc. Manufacture of lozenge product with radiofrequency
US8581001B2 (en) 2010-04-16 2013-11-12 Codman & Shurtleff Metformin-cysteine prodrug
US9119793B1 (en) 2011-06-28 2015-09-01 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for doxycycline
CN102258497B (zh) * 2011-08-18 2013-01-09 海南良方医药有限公司 一种拉米夫定片剂组合物及其制备方法
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
US10842802B2 (en) 2013-03-15 2020-11-24 Medicis Pharmaceutical Corporation Controlled release pharmaceutical dosage forms
CN103432091A (zh) * 2013-09-13 2013-12-11 钟术光 一种性能改善的片剂及其制备方法
MX368159B (es) 2014-01-10 2019-09-20 Johnson & Johnson Consumer Inc Proceso para elaborar tabletas con el uso de radiofrecuencia y partículas disipativas revestidas.
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
AR118419A1 (es) 2019-02-22 2021-10-06 Catalent Uk Swindon Zydis Ltd Minimización de aglomeración de material de revestimiento de partícula de medicamento durante el almacenaje para estabilizar los tiempos de desintegración de productos farmacéuticos
US11185508B2 (en) 2019-02-22 2021-11-30 Catalent U.K. Swindon Zydis Limited Preserving functionally-coated API particles produced by solventless mixing processes in aqueous suspension
JP7628497B2 (ja) 2019-02-22 2025-02-10 キャタレント・ユーケー・スウィンドン・ザイディス・リミテッド イブプロフェンを含む薬学的組成物の凝集、通気の最小化、及びコーティングの保存
PH12021552026A1 (en) 2019-02-22 2022-08-22 Catalent Uk Swindon Zydis Ltd Minimizing aeration of suspensions during in-line mixing
US11179331B1 (en) 2020-04-21 2021-11-23 Cure Pharmaceutcai Holding Corp Oral soluble film containing sildenafil citrate
RS63725B1 (sr) 2020-05-18 2022-12-30 Orexo Ab Nova farmaceutska kompozicija za davanje leka
EP4188324A1 (en) 2020-07-31 2023-06-07 Catalent U.K. Swindon Zydis Limited Pharmaceutical compositions comprising coated api
WO2023094826A1 (en) 2021-11-25 2023-06-01 Orexo Ab Pharmaceutical composition comprising adrenaline
GB202117016D0 (en) 2021-11-25 2022-01-12 Orexo Ab New pharmaceutical device

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166440A2 (en) * 1984-06-28 1986-01-02 THE PROCTER & GAMBLE COMPANY Antacid composition
GB2293099A (en) * 1994-09-15 1996-03-20 Mailway Packaging Group Ltd Drug formulation
WO1999043306A1 (en) * 1998-02-26 1999-09-02 Banyu Pharmaceutical Co., Ltd. An orally disintegrating composition and its manufacturing method
EP0960621A2 (en) * 1998-05-15 1999-12-01 Pfizer Inc. Pharmaceutical formulations comprising sildenafil

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946684A (en) * 1989-06-20 1990-08-07 American Home Products Corporation Fast dissolving dosage forms
ES2162867T3 (es) * 1993-07-09 2002-01-16 Scherer Corp R P Metodo de fabricacion de formas de dosificacion de farmacos liofilizados.
US5622719A (en) * 1993-09-10 1997-04-22 Fuisz Technologies Ltd. Process and apparatus for making rapidly dissolving dosage units and product therefrom
TR199802068T2 (xx) * 1996-04-16 2000-01-21 Novartis Consumer Health S.A. H�zl� b�l�nen oral doz formu.

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166440A2 (en) * 1984-06-28 1986-01-02 THE PROCTER & GAMBLE COMPANY Antacid composition
GB2293099A (en) * 1994-09-15 1996-03-20 Mailway Packaging Group Ltd Drug formulation
WO1999043306A1 (en) * 1998-02-26 1999-09-02 Banyu Pharmaceutical Co., Ltd. An orally disintegrating composition and its manufacturing method
EP0960621A2 (en) * 1998-05-15 1999-12-01 Pfizer Inc. Pharmaceutical formulations comprising sildenafil

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0247607A3 *

Also Published As

Publication number Publication date
WO2002047607A2 (en) 2002-06-20
AU2002220968A1 (en) 2002-06-24
EP1343481A2 (en) 2003-09-17
WO2002047607A3 (en) 2003-03-20
IN192750B (enrdf_load_stackoverflow) 2004-05-15

Similar Documents

Publication Publication Date Title
EP1343481A4 (en) PROCESS FOR THE PREPARATION OF A QUICKLY SOLUBLE DOSAGE FORM
EG24851A (en) Crystalline anticholinergic process for the preparation thereof for preparing a medicament
IL154012A0 (en) Hydrogel-driven drug dosage form
HUP0300327A3 (en) Percyquinnin, a process for its production and its use as a pharmaceutical
HUP0402027A3 (en) Process for the preparation of a xantophyll
AU2002341241A1 (en) Process for the preparation of fast dissolving dosage form
IL134241A0 (en) A new process for the preparation of latanoprost
IL153505A0 (en) Dds compound and process for the preparation thereof
HRP20040161A2 (en) Process for the preparation of a 14-hydroxynormorphinone derivative
IL187126A0 (en) Process for the preparation of 4 - haloalkylnicotinonitriles
HUP0104272A3 (en) New cyclobutendione compounds, a process for their preparation and pharmaceutical compositions containing them
IL156145A0 (en) Process for the preparation of phenethylamine derivatives
AU8824201A (en) Process for the preparation of dinapsoline
IL153532A0 (en) Process for the preparation of pyrazolopyrimidinones
IL148176A0 (en) Bioavailable dosage form of isotretinoin
HUP0302765A3 (en) A process for the preparation of taxan derivatives
HUP0101875A3 (en) Process for the preparation of piperidine derivatives
HUP0105328A3 (en) Bicyclic amino-pirazinone compounds, a process for their preparation and pharmaceutical compositions containing them
IL150897A0 (en) Process for the preparation of acetyl-amidiniophenylalanyl cyclohexylglycyl-pyridinioalaninamides
GB0108016D0 (en) Process for the preparation of a catalyst
IL137364A0 (en) A process for the preparation of 6,6-dimethylhept-1-en-4-yn-3-ol
IL190807A0 (en) Process for the preparation of 2-aminoethylpyridines
AU2001282071A1 (en) Multiparticulate pharmaceutical dosage form and a method for producing the same
HRP20000490B1 (en) Process for the preparation of amlodipine besilate
GB0108017D0 (en) Process for the preparation of a catalyst

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

17P Request for examination filed

Effective date: 20030922

A4 Supplementary search report drawn up and despatched

Effective date: 20040204

17Q First examination report despatched

Effective date: 20060913

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070124